Quantum News
Sign InSign Up
Back to News
research

Strata Critical Medical, Inc. (SRTA) Q4 2025 Earnings Call Transcript

Seeking Alpha
Loading...
2 min read
0 likes
⚡ Quantum Brief
Strata Critical Medical reported Q4 2025 earnings on March 3, 2026, highlighting financial performance for the period ending December 31, 2025. Co-CEOs Melissa Tomkiel and William Heyburn led the call, addressing analysts and investors. The company emphasized forward-looking statements, warning of potential risks under the Private Securities Litigation Reform Act of 1995. Investors were directed to SEC filings for detailed risk factors that could impact future results. CFO Mathew Schneider opened the call, outlining financial disclosures and regulatory compliance. The discussion included operational updates and strategic priorities for 2026, though specific figures were not detailed in the transcript excerpt. Analysts from B. Riley Securities, Lake Street Capital, and Ladenburg Thalmann participated, signaling strong institutional interest. Questions focused on financial health, growth projections, and market positioning. The call underscored Strata’s focus on transparency, risk management, and investor communication amid evolving market conditions. No breakthrough announcements were made, but leadership reaffirmed long-term strategic confidence.
AI Audio Summary
0:00 / 0:00
Click to play
pexels-thisisengineering-3861969 (1).jpg
Quantum News · Media Library

Understand this faster with AI

ChatGPTAsk ChatGPTPerplexityResearch with PerplexityClaudeExplain with ClaudeGrokDiscuss on Grok

SA Transcripts158.77K FollowersFollow5ShareSaveCommentsPlay Earnings CallPlay Earnings Call Strata Critical Medical, Inc. (SRTA) Q4 2025 Earnings Call March 3, 2026 8:00 AM EST Company Participants Mathew Schneider - CFO of Clinical Services & VP of Finance and Investor RelationsMelissa Tomkiel - Co- CEO, General Counsel & DirectorWilliam Heyburn - Co- CEO, CFO & Director Conference Call Participants Yuan Zhi - B. Riley Securities, Inc., Research DivisionBenjamin Haynor - Lake Street Capital Markets, LLC, Research DivisionJon Hickman - Ladenburg Thalmann & Co. Inc., Research Division Presentation Operator Good morning, ladies and gentlemen, and welcome to the Strata Critical Medical Fiscal Fourth Quarter 2021 Earnings Release Conference Call. [Operator Instructions] As a reminder, this call is being recorded. I would now like to turn the conference call over to Matt Schneider, CFO of Clinical Services as Vice President of Finance and Investor Relations. Matt, you may begin. Mathew SchneiderCFO of Clinical Services & VP of Finance and Investor Relations Thank you for standing by, and welcome to Strata 's conference call and webcast for the quarter ended December 31, 2025. We appreciate everyone joining us today. Before we get started, I would like to remind you of the company's forward-looking statement and safe harbor language. Statements made in this conference call that are not historical facts, including statements about future time periods, may be deemed to constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to risks and uncertainties, and actual future results may differ materially from those expressed or implied by the forward-looking statements. We refer you to our SEC filings, including our annual report on Form 10-K and our quarterly report on Form 10-Q, each as filed with the SEC for a more detailed discussion of the risk factors that could cause these differences.

Read Original

Source Information

Source: Seeking Alpha

Discussion

0 professional contributions

Sign in to join this professional discussion.

Be the first to add a constructive contribution.